FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.

Stein L, Murugesan K, Reeser JW, Risch Z, Wing MR, Paruchuri A, Samorodnitsky E, Hoskins EL, Dao T, Smith A, Le D, Babcook MA, Chang YS, Avenarius MR, Imam M, Freud AG, Roychowdhury S

Open source

DOI: 10.1038/s41698-024-00683-x
Published: 2024 Sep 17
Container: NPJ precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-024-00683-x,
  title = {FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.},
  author = {Stein L and Murugesan K and Reeser JW and Risch Z and Wing MR and Paruchuri A and Samorodnitsky E and Hoskins EL and Dao T and Smith A and Le D and Babcook MA and Chang YS and Avenarius MR and Imam M and Freud AG and Roychowdhury S},
  year = {2024},
  journal = {NPJ precision oncology},
  doi = {10.1038/s41698-024-00683-x},
  url = {https://doi.org/10.1038/s41698-024-00683-x}
}

RIS

TY  - JOUR
TI  - FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.
AU  - Stein L
AU  - Murugesan K
AU  - Reeser JW
AU  - Risch Z
AU  - Wing MR
AU  - Paruchuri A
AU  - Samorodnitsky E
AU  - Hoskins EL
AU  - Dao T
AU  - Smith A
AU  - Le D
AU  - Babcook MA
AU  - Chang YS
AU  - Avenarius MR
AU  - Imam M
AU  - Freud AG
AU  - Roychowdhury S
PY  - 2024
JO  - NPJ precision oncology
DO  - 10.1038/s41698-024-00683-x
UR  - https://doi.org/10.1038/s41698-024-00683-x
ER  -

APA

L, S., K, M., JW, R., Z, R., MR, W., A, P., E, S., EL, H., T, D., A, S., D, L., MA, B., YS, C., MR, A., M, I., AG, F., & S, R. (2024). FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.. NPJ precision oncology. https://doi.org/10.1038/s41698-024-00683-x

Source records

pubmed · retrieved 2026-09-26T22:45:29.557Z